Compositions and Methods Useful for HCV Infection

Details for Australian Patent Application No. 2008201814 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Kwong, Ann; Reid, Lola M; Byrn, Randal

Agent Cullen & Co

Pub. Number AU-B-2008201814

Parent 2002306946

Filing date 24 April 2008

Wipo publication date 15 May 2008

Acceptance publication date 3 July 2008

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

Event Publications

15 May 2008 Application Open to Public Inspection

  Published as AU-B-2008201814

15 May 2008 Complete Application Filed

3 July 2008 Application Accepted

  Published as AU-B-2008201814

30 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201815-Concrete screed

2008201813-Pool Cover